Meridian Bioscience, Inc.
As of: July 24, 2008Back to 600 Directory
www.meridianbioscience.com
InvestorRelations
BusinessSummary
RelativeStandings
Key Statistics
Key Stock Statistics — Fiscal Year Ending Sep. 30
Tang. Bk. Value/Share
2.35
Beta
1.01
Dividend Rate/Share
0.56
Shareholders
27,000
Shs. outstg. (M)
40
Market cap. (B)
$1.034
Avg. daily vol. (M)
.390
Inst. holdings
78%
Value of $10,000 invested 5 years ago: $57,499.39
Revenue (Millions $)
2008
2007
2006
2005
2004
2003
Q1
36.20
28.72
24.91
18.84
18.17
16.10
Q2
36.25
32.09
28.27
23.69
20.94
16.91
Q3
33.07
29.76
26.58
25.42
18.26
15.69
Q4
----
32.39
28.65
25.02
22.24
17.16
Year
122.96
108.41
92.97
79.61
65.86
Earnings Per Share
.18
.14
.10
.06
.05
.04
.15
.12
.09
.07
.19
.22
.16
.08
.66
.45
.35
.27
.21
Per Share Data ($)
2002
2001
2000
1999
1998
Tangible Bk. Val.
1.89
1.58
.53
.36
.24
.20
.80
Cash Flow
.72
.52
.47
.39
.32
.26
-.17
.25
Net Inc. ($ Millions)
26.70
18.33
12.57
9.19
7.02
5.03
-10.28
7.11
2.39
4.96
Dividend Data (Dividends have been paid since 1990)
Amount ($)
Date Decl.
Ex-Div. Date
Stock of Record
Payment Date
0.11
Nov. 14
Nov. 21
Nov. 26
Dec. 3‘07
0.14
Jan. 22
Jan. 29
Jan. 31
Feb. 7‘08
Apr. 17
Apr. 24
Apr. 28
May 5‘08
Jul. 17
Jul. 28
Jul. 30
Aug. 7‘08
A Standard & Poor’s SmallCap 600 Company
Standard & Poor’s a division of The McGraw-Hill Companies